Since its inauguration in 2003, China Interventional Therapeutics （CIT） congress has witnessed the growth of percutaneous cardiovascular intervention in China. In 2003 the total number ofpercutaneous coronary interv...Since its inauguration in 2003, China Interventional Therapeutics （CIT） congress has witnessed the growth of percutaneous cardiovascular intervention in China. In 2003 the total number ofpercutaneous coronary intervention （PCI） in China was about 40 000 cases,1 while by CIT＇s 10th anniversary in 2012, the annual number of PCI in China had reached 340 000 cases. CIT has grown along with PCI practice in the country; last year the CIT congress hosted 6000 attendees, including 180 international faculty members and over 750 foreign participants from 42 countries or regions.展开更多
文摘Since its inauguration in 2003, China Interventional Therapeutics （CIT） congress has witnessed the growth of percutaneous cardiovascular intervention in China. In 2003 the total number ofpercutaneous coronary intervention （PCI） in China was about 40 000 cases,1 while by CIT＇s 10th anniversary in 2012, the annual number of PCI in China had reached 340 000 cases. CIT has grown along with PCI practice in the country; last year the CIT congress hosted 6000 attendees, including 180 international faculty members and over 750 foreign participants from 42 countries or regions.
